Zobrazeno 1 - 6
of 6
pro vyhledávání: '"33"'
Autor:
G Tsariktsian, Ricardo Forastiero, L O Carreras, M M Sturno, B. Alonso, M. E. Martinuzzo, G F de Larrañaga
Publikováno v:
Lupus. 9:594-600
Antiphospholipid antibodies (aPL) have been reported not only in autoimmune disorders but also in various infectious diseases. Accumulating evidence indicates that b2glycoprotein I (b2GPI) and prothrombin are the main proteins to which autoimmune aPL
Autor:
Guillermo Ruiz-Irastorza, Jose Gabriel Erdozain, Irama Villar, Ciriaco Aguirre, Maider Garmendia, Agustin Martinez-Berriotxoa, Maria-Victoria Egurbide
Publikováno v:
Lupus. 16(10)
Fluctuations in the titers of anticardiolipin antibodies (aCL) have been reported in systemic lupus erythematosus (SLE) patients, but their relation with thrombosis is not completely understood. Prospective inception cohort of 237 patients with SLE (
Publikováno v:
Lupus. 16(2)
Seventy-two patients with antiphospholipid antibodies (aPL), with or without antiphospholipid syndrome (APS), were studied for detection of heparin-PF4-induced antibodies (HPIA) using a commercial kit (Asserachrom® HPIA) PF4-dependant enzyme-linked
Autor:
A.J. Chamorro, Jordi Yagüe, J C Botero, Miguel Ingelmo, S Segura, Ricard Cervera, Manuel Ramos-Casals, Josep Font, G Salvador, M T Campoamor
Publikováno v:
Lupus. 13(10)
The objective of the study was to analyse the prevalence and clinical significance of hypocomplementemia in a large series of patients diagnosed either with systemic lupus erythematosus (SLE) or with primary antiphospholipid syndrome (APS) and its as
Autor:
A F Masri, Nora Pashayan, Thurayya Arayssi, S Shaar, Samir F. Atweh, Stella Major, Imad Uthman, R Chidiac-Tannoury
Publikováno v:
Lupus. 11(11)
The objective of the study was to describe the practice patterns of the antiphospholipid syndrome (APS) as compared with consensus guidelines for diagnosis and to determine whether practice patterns correlate with patient demographics and physician s
Autor:
Juan Carlos Reverter, Ricard Cervera, F. J. Muñoz-Rodriguez, Josep Font, Gerard Espinosa, Francisco Carmona, Juan Balasch, Dolors Tàssies, Antonio Ordinas, Miguel Ingelmo
Publikováno v:
Lupus. 11(11)
Antiphospholipid antibodies (aPL) may induce acquired activated protein C resistance (acquired APCR). The role of acquired APCR in patients with systemic lupus erythematosus (SLE) is not well known. To evaluate the prevalenceof acquiredAPCR and its a